Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tadpa RD 30mg/20mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Atyad Life Sciences Pvt Ltd

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Tadpa RD 30mg/20mg Capsule SR

Gastroesophageal reflux disease (GERD, or acid reflux) is effectively managed with the combination medication, Tadpa RD 30mg/20mg Sustained-Release Capsules. This treatment alleviates common GERD symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration for Tadpa RD are determined by your physician and should be taken on an empty stomach. Treatment adherence as directed is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Comprehensive disclosure of all other medications to your healthcare provider is essential due to potential interactions. Common, typically transient, side effects include diarrhea, abdominal discomfort, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are possible; avoid driving or activities requiring concentration until the effects are known. Alcohol consumption should be avoided to minimize drowsiness. Lifestyle adjustments such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate may enhance treatment outcomes. Prior to commencing treatment, inform your doctor of any existing liver or kidney conditions, as well as pregnancy, pregnancy planning, or breastfeeding.

Uses of Tadpa RD 30mg/20mg Capsule SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Tadpa RD 30mg/20mg Capsule SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tadpa RD 30mg/20mg SR capsule whole; do not crush, chew, or break it. Administer on an empty stomach.

Common Side effects of Tadpa RD 30mg/20mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Tadpa RD 30mg/20mg Capsule SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tadpa RD 30mg/20mg Capsule SR whole; do not crush, chew, or break it. Administer on an empty stomach.

How Tadpa RD 30mg/20mg Capsule SR works:

Tadpa RD 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, acting synergistically to manage gastrointestinal distress. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract movement, facilitating efficient food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, thereby alleviating acid reflux symptoms such as indigestion and heartburn.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Tadpa RD 30mg/20mg SR capsules with alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tadpa RD 30mg/20mg SR Capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before taking this medicine.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Tadpa RD 30mg/20mg capsules are likely not suitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving should be avoided if you experience drowsiness, blurred vision, dizziness, or reduced awareness after taking Tadpa RD 30mg/20mg SR Capsules. These side effects are possible.

KidneyKidneyCAUTION

Renal impairment necessitates careful administration of Tadpa RD 30mg/20mg sustained-release capsules. Dosage modification for Tadpa RD 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Tadpa RD 30mg/20mg SR capsules cautiously, potentially requiring dosage modification. Consult a physician for guidance. Tadpa RD 30mg/20mg SR capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.

What if you forget to take Tadpa RD 30mg/20mg Capsule SR :

Should you forget a Tadpa RD 30mg/20mg SR Capsule, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Tadpa RD 30mg/20mg Capsule SR

LabelValue
Potential for Dependence None.
Type of Medication Stomach and intestinal

FAQs on Tadpa RD 30mg/20mg Capsule SR

Tadpa RD 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual medication addresses heartburn, acidity, and gastroesophageal reflux disease (GERD), a condition characterized by stomach acid reflux into the esophagus. It's also indicated for gastric and duodenal ulcers. Domperidone's action involves enhancing gut motility, thereby facilitating smoother food passage through the stomach and managing nausea and vomiting.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any Tadpa RD 30mg/20mg Capsule SR excipients should avoid this medication. Individuals with pre-existing hepatic or renal impairment require careful monitoring while using this drug.
Indeed, Tadpa RD 30mg/20mg SR capsules can induce xerostomia. This side effect is attributed to the Domperidone component. To alleviate dry mouth, increase your fluid intake. Keep water readily available overnight. Reduce alcohol consumption and refrain from smoking. Should dry mouth persist, utilize alcohol-free mouthwash to mitigate the potential for dental caries.
Diarrhea is a potential side effect of Tadpa RD 30mg/20mg SR Capsules. If diarrhea occurs, increased fluid intake is recommended. A low-fat diet is advisable while taking this medication. Consult your physician if diarrhea continues or if dehydration symptoms, such as decreased urination and dark, strong-smelling urine, appear.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the label or packaging. Discard any leftover medication. Ensure its inaccessibility to children, pets, and others.
Tadpa RD 30mg/20mg SR capsules are generally well-tolerated. Nevertheless, some individuals may experience common adverse reactions including diarrhea, abdominal pain, flatulence, dry mouth, vertigo, and headache; less frequent or rare side effects are also possible. Report any ongoing issues to your physician during treatment.
Optimal absorption of Tadpa RD 30mg/20mg sustained-release capsules is achieved by administration prior to the initial meal or while fasting.
Taking Tadpa RD 30mg/20mg SR Capsules may raise the likelihood of an irregular heartbeat, a potentially severe arrhythmia. While this is a serious adverse event, the probability is quite small. The risk might be marginally elevated for individuals over 60.
Tadpa RD 30mg/20mg SR capsules contain Domperidone and Rabeprazole, addressing acidity, heartburn, and gastroesophageal reflux disease (GERD)—a condition causing stomach acid to reflux into the esophagus. This medication also manages gastric and duodenal ulcers. The Domperidone component facilitates improved gut motility, thus easing food passage through the stomach and mitigating vomiting.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any Tadpa RD 30mg/20mg Capsule SR excipient should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring while taking this medication.
Dry mouth is a potential side effect of Tadpa RD 30mg/20mg SR Capsules, specifically attributed to the Domperidone component. Increased water consumption is recommended to alleviate this symptom. Keeping water readily available, especially overnight, is helpful. Reducing alcohol consumption and abstaining from smoking are also advisable. Individuals experiencing dry mouth should opt for alcohol-free mouthwash to minimize the potential for dental problems.
Diarrhea is a potential side effect of Tadpa RD 30mg/20mg SR Capsules. If diarrhea occurs, increased fluid intake is recommended. Fatty or fried foods should be avoided while taking this medication. Consult your physician if diarrhea continues or if dehydration symptoms, such as reduced urination and dark, strong-smelling urine, appear.
Tadpa RD 30mg/20mg SR capsules are generally well-tolerated. Nevertheless, some individuals may experience typical adverse reactions such as diarrhea, abdominal pain, gas, dry mouth, vertigo, or headache. Less frequent or infrequent side effects are also possible. Report any ongoing issues to your physician during treatment.
Optimal absorption of Tadpa RD 30mg/20mg sustained-release capsules is achieved when taken before breakfast or while fasting.
Taking Tadpa RD 30mg/20mg Capsule SR may raise the likelihood of an irregular heartbeat, a potentially serious arrhythmia. While this adverse effect is rare, it's important to be aware of it. The risk might be somewhat elevated for individuals over 60.
Maintain this medication within its original, sealed container. Storage should follow the directions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Tadpa RD 30mg/20mg Capsul...
73
MRP 89
17% off